Cartesian Therapeutics grants new hires stock options for 115,250 shares under inducement plan
RNAC•Inducement stock option grants to four new hires
Cartesian Therapeutics granted inducement stock options covering 115,250 shares to four newly hired employees, with grant dates of Aug. 3, 2026 and Aug. 6, 2026.
The exercise price was set at the Nasdaq closing price on each grant date, and the options carry a 10-year term.
Vesting spans four years: 25% after one year, with the remainder vesting in monthly installments, reaching full vesting in August 2030.
